Skip to content

Clinical trials

Phase 3 Bipolar Disorder trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 3 Country / region: Russia Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20045
20055
20063
20093
20111
20122
20131
20141
20161
20171
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sumitomo Pharma America, Inc.6
AstraZeneca3
Intra-Cellular Therapies, Inc.3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
Novartis Pharmaceuticals2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Eli Lilly and Company1
Janssen Pharmaceutica N.V., Belgium1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Sumitomo Pharma Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder24
Mania4
Schizophrenia3
Affective Disorders, Psychotic1
Autistic Disorder1
Major Depressive Disorder1
Mood Disorders1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.